
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you open and fund a new account within 30 days
- Access to a financial planner
Aspira Womens Health is a diagnostics & research business based in the US. Aspira Womens Health shares (AWH) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.03 – the same closing value as a week prior. Aspira Womens Health employs 66 staff and has a trailing 12-month revenue of around $9.2 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Latest market close | $0.03 |
---|---|
52-week range | $0.02 - $3.28 |
50-day moving average | $0.12 |
200-day moving average | $0.64 |
Wall St. target price | $5.50 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.93 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.027 from 2025-04-17
1 week (2025-04-24) | N/A |
---|---|
1 month (2025-04-04) | -71.28% |
3 months (2025-02-05) | -92.72% |
6 months (2024-11-05) | -96.88% |
1 year (2024-05-03) | -99.16% |
---|---|
2 years (2023-05-04) | -99.40% |
3 years (2022-05-04) | 10.551 |
5 years (2020-05-01) | 23.55 |
Revenue TTM | $9.2 million |
---|---|
Gross profit TTM | $5.5 million |
Return on assets TTM | -173.13% |
Return on equity TTM | -723.45% |
Profit margin | -142.61% |
Book value | $-0.15 |
Market Capitalization | $2.9 million |
TTM: trailing 12 months
We're not expecting Aspira Womens Health to pay a dividend over the next 12 months.
Aspira Womens Health's shares were split on a 1:15 basis on 11 May 2023 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aspira Womens Health shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Aspira Womens Health shares which in turn could have impacted Aspira Womens Health's share price.
Over the last 12 months, Aspira Womens Health's shares have ranged in value from as little as $0.0216 up to $3.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aspira Womens Health's is 2.014. This would suggest that Aspira Womens Health's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aspira Women's Health Inc. , together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis. The company also operates Aspira Labs, a laboratory that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC.
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Compare pros, cons, research tools and reviews for these two trading platforms.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.